Published in Pharma Law Weekly, December 26th, 2006
This trend article about University of Oxford, U.K., is an immediate alert from NewsRx to identify developing directions of research.
"Variation in the performance of this assay has been attributed to V3 sequence heterogeneity,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.